SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-252860
Filing Date
2017-08-09
Accepted
2017-08-09 16:35:00
Documents
46
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d439476d10q.htm 10-Q 517733
2 EX-10.1 d439476dex101.htm EX-10.1 54213
3 EX-31.1 d439476dex311.htm EX-31.1 10137
4 EX-31.2 d439476dex312.htm EX-31.2 10353
5 EX-32.1 d439476dex321.htm EX-32.1 6201
  Complete submission text file 0001193125-17-252860.txt   3908355

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT hrtx-20170630.xml EX-101.INS 998530
7 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20170630.xsd EX-101.SCH 31403
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20170630_cal.xml EX-101.CAL 27691
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20170630_def.xml EX-101.DEF 232093
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20170630_lab.xml EX-101.LAB 218701
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20170630_pre.xml EX-101.PRE 245846
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 171018406
SIC: 2834 Pharmaceutical Preparations